Nu-Tek BioSciences Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
Nu-Tek BioSciences General Information
Description
Developer and manufacturer of peptones and protein hydrolysates intended for a variety of applications in pharmaceuticals and industrial fermentations. The company uses proprietary processes to produce peptones, such as soy peptones, pea peptones, and yeast extracts, which have been proven to increase growth rates and yields, enabling biotech and wellness food industries to manufacture animal-free and allergen-free probiotics.
Contact Information
Website
www.nu-tekbiosciences.comCorporate Office
- 5400 Opportunity Court
- Suite 120
- Minnetonka, MN 55343
- United States
Corporate Office
- 5400 Opportunity Court
- Suite 120
- Minnetonka, MN 55343
- United States
Nu-Tek BioSciences Timeline
Nu-Tek BioSciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 14-Jul-2025 | Completed | Generating Revenue | |||
| 2. Seed Round | 21-Jun-2023 | Completed | Generating Revenue | |||
| 1. Grant | 28-Apr-2021 | $500K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Nu-Tek BioSciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nu-Tek BioSciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nu-Tek BioSciences Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent Capital | Venture Capital | Minority | ||
| 1315 Capital | Growth/Expansion | Minority | ||
| Minnesota Department of Employment and Economic Development | Government |
Nu-Tek BioSciences FAQs
-
When was Nu-Tek BioSciences founded?
Nu-Tek BioSciences was founded in 2009.
-
Where is Nu-Tek BioSciences headquartered?
Nu-Tek BioSciences is headquartered in Minnetonka, MN.
-
What is the size of Nu-Tek BioSciences?
Nu-Tek BioSciences has 26 total employees.
-
What industry is Nu-Tek BioSciences in?
Nu-Tek BioSciences’s primary industry is Biotechnology.
-
Is Nu-Tek BioSciences a private or public company?
Nu-Tek BioSciences is a Private company.
-
What is Nu-Tek BioSciences’s current revenue?
The current revenue for Nu-Tek BioSciences is .
-
How much funding has Nu-Tek BioSciences raised over time?
Nu-Tek BioSciences has raised $1.68M.
-
Who are Nu-Tek BioSciences’s investors?
Agent Capital, 1315 Capital, and Minnesota Department of Employment and Economic Development have invested in Nu-Tek BioSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
